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Abstract
Background: Weight gain is common after breast cancer (BC) treatment and may increase the risk of disease
recurrence. Complementary medicine (CM) use is high amongst BC patients. This paper describes the use of CM
from a cross-sectional self-administered survey on prevalence and management of weight after BC.
Methods: Use of CM was assessed using a question modified from the I-CAM Questionnaire. Participants were
asked to rate perceived effectiveness, advantages and disadvantages, and which CM they were willing to use for
weight management if there was evidence for effectiveness. The survey was emailed to members of the Breast
Cancer Network Australia Survey and Review Group, the largest consumer advocacy group in Australia for people
with breast cancer.
Results: There were a total of 309 responses. Three quarters had used CM in the past 12 months. One third had
tried CM for weight loss. Yoga, meditation and pilates were perceived to be effective for weight loss. Perceived
advantages of CMs for weight loss were the ability to improve general wellbeing, relaxation, and being non-
pharmacological while disadvantages were financial cost, finding a reliable practitioner, and lack of research for
effectiveness. Three quarters would be willing to try CM for weight loss if there was evidence for effectiveness,
with the most popular CMs being acupuncture, relaxation, yoga, supplements, and meditation.
Conclusions: The high use of CM in this group is consistent with previous research. Our research suggests that BC
survivors would use acupuncture, meditation, supplements and yoga for weight loss if supported by scientifically-
credible evidence. Research into the effectiveness of these treatments on weight loss after BC is warranted.
Keywords: Breast cancer, DCIS, Complementary medicine, Overweight, Obesity, Weight gain, Australian women,
National survey, Prevalence
Background
Complementary medicine (CM) or complementary
therapies refer to ‘a group of diverse medical and
healthcare systems, practices and products that are not
generally considered part of conventional medicine’ [1].
In this paper, the terms “complementary medicine”,
“complementary therapies” and “complementary and al-
ternative medicine” are used synonymously. Boundaries
within CM and between the CM domain and that of
the dominant system are not always clearly defined or
fixed [2]. Women with breast cancer (BC) are the most
likely group to use CM out of all cancer patients [3]
with CM use reportedly as high as 75% [4]. Patients
with breast cancer using CM are mostly younger and
more highly educated than non-CM users in the major-
ity of studies. Some studies have also shown that
women with breast cancer using CM had higher in-
come than those who did not [3]. An association be-
tween CM use and more advanced breast cancer at
diagnosis has also been found [5].
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Weight gain is common after a breast cancer diagnosis
and may increase the risk of disease recurrence and all-
cause mortality, increase the burden of chronic disease
from obesity-related disorders such as cardiovascular
disease and diabetes, and have a significantly negative
impact on quality of life [6]. Weight gain after a BC
diagnosis is thought to be multifactorial and related to
the use of systemic treatment as well as changes in life-
style [6, 7]. There is emerging evidence for the use of
some CM to assist weight loss in the general population.
However, little is known about the use of CM for weight
loss amongst women with BC, making it important to
understand patterns and drivers of use of CM amongst
women with BC.
The aim of this national survey was to describe the use
of CM for weight management after BC in Australian
women.
Methods
Study design and inclusion criteria
We conducted a cross-sectional self-administered an-
onymous survey using Qualtrics online survey software
[8]. Any woman living in Australia who self-identified as
having BC was eligible to complete the survey. We
recruited mainly from the Breast Cancer Network
Australia (BCNA) Review and Survey Group (n = 1857),
representing approximately 2% of all BCNA members,
who had agreed to receive emails about research studies.
BCNA is the largest breast cancer advocacy group in
Australia, and their Review and Survey Group is one of
the largest breast cancer consumer groups available for
research, representing an important source of feedback
for the research community. By limiting research at
BCNA to the Review and Survey group, researchers have
access to women who are engaged in the research
process, while the remainder of BCNA members are
protected from frequent research requests. We also re-
cruited through other online communities (women’s
health organization social media pages and online breast
cancer support groups in Australia).
The survey was emailed on December 5th, 2017 and a
reminder email was sent to 1835 members on January
15th, 2018 (Appendix). Ethics approval was provided by
the Human Research Ethics Committee, Western Sydney
University (H12444, Oct 2017).
Survey instrument
This study is drawn from a larger study exploring the
prevalence, predictors and management of weight after
breast cancer amongst women in Australia (Ee C, Cave
A, Naidoo D, Boyages J. Weight before and after a diag-
nosis of breast cancer or Ductal Carcinoma In Situ: a na-
tional Australian survey/under review). The survey was
developed after reviewing previous literature on weight
after breast cancer and was later revised to include feed-
back from six BCNA representatives and several health
researchers. The 60-item survey included questions on
the sociodemographic characteristics, medical details
such as diagnosis and treatment, lifestyle habits, and
weight and weight management of women (see Appen-
dix for further details). In this paper, we report on com-
plementary therapy use for any condition and for weight
management. Further analyses from our data will in-
clude predictors of weight gain in our sample, but are
not reported in this manuscript.
Weight after diagnosis
Women were asked to self-report their weight in
kilograms (kg) at the time of diagnosis, and current
weight and height (in meters). Body Mass Index (BMI)
was calculated from weight and height as weight/height2
and reported in kg/m2. BMI was classified as under-
weight (< 20 kg), healthy weight (BMI ≥ 20 and < 25),
overweight (BMI ≥ 25 and < 30) and obese (BMI ≥ 30)
[9]. The pattern of weight since diagnosis was also
assessed as “gained weight overall”, “lost weight overall”,
“weight stable” or “weight has fluctuated a great deal”.
Weight at diagnosis was reported by 90% of total re-
spondents (277 women) and current weight by 95% of
respondents (293 women).
Complementary therapies
Women were asked about their use of CM for any
condition, and also specifically for weight loss, in the
past 12 months. This question was modified from the
International Questionnaire to Measure.
Use of Complementary and Alternative Medicine (I-
CAM Questionnaire) [10] which is culture-neutral and
does not promote one modality over another although
we have slightly modified the terminology to suit an
Australian population [10]. CM use is divided into visits
to complementary therapists (e.g. acupuncturists, chiro-
practors), use of herbal medicine and dietary supple-
ments (defined as vitamins, minerals, herbs and
antioxidants), and of self-help practices (e.g. yoga). Par-
ticipants were asked to rate the perceived usefulness of
chosen CM by selecting one option on a 7- point Likert
scale ranging from ‘strongly agree’ to ‘strongly disagree’,
in response to the statement “I found this therapy to be
effective for my condition and/or helpful for me overall”
or “I found this therapy to be effective in helping me
manage my weight”. We further trichomotised the re-
sponses into ‘strongly agree/agree (effective)’, ‘somewhat
agree/neither agree nor disagree (neutral)’, and ‘some-
what disagree, disagree, strongly disagree (not effective)’.
Data on visits to conventional health practitioners
(general practitioner/primary care physician, oncologist,
allied health) over the past 12 months were also
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collected. Finally, we asked women about the perceived
advantages and disadvantages of using CM for weight
management and which CM they were willing to use for
weight management if there was research evidence to
demonstrate effectiveness. Women were given a selec-
tion of responses to choose from and could also provide
free text answers for additional comment.
Statistical analysis
IBM SPSS statistics package version 23 [11] and Stata
statistical software [12] were used to analyse the data
presented in this report. We used descriptive statistics to
present the majority of the data, and Pearson’s chi-
square to identify associations between weight gain and
CM use, and advanced breast cancer (metastatic or in-
flammatory) and CM use. To explore differences in
demographic characteristics between respondents who
were from the BCNA Review and Survey group vs non
BCNA respondents, we used Pearson’s chi-square, linear
regression and independent samples t-tests.
Results
Survey response
Of the 1857 BCNA members, 283 (15%) responded to
the survey. A further 26 women responded to the survey
from other channels giving a total of 309 responses.
Sample characteristics
Demographic and clinical characteristics of respondents
are described in Table 1. The majority of women were
Caucasian (92.5%, n = 285) with a mean age of 59.1 years
(SD = 9.5, range 33–78, n = 298). Characteristics were
similar across BCNA members and non-BCNA respon-
dents except that there was a higher proportion of
women in the non-BCNA group who were self-
employed (23% vs 10%) and in the BCNA group who
were retired (33% vs 23%), however this difference was
not statistically significant on Pearson’s chi-square
testing, X2 (7,N = 307) = 6.9912, p = 0.430. There was
also no statistically significant correlation between age
and type of employment apart from doing voluntary
work (p = 0.05), and no difference in age between BCNA
and non-BCNA respondents (p = 0.0759). The majority
of women (82%, n = 252) had been diagnosed with non-
metastatic BC. The mean time since diagnosis of BC was
8.2 years (SD 5.12, range 1–32 years) and mean age at
diagnosis was 50.9 years (SD = 9.02, range 29–74). The
majority of women were diagnosed either Ductal
Carcinoma in Situ or localized breast cancer. There was
no association between more advanced cancer and use
of any complementary medicine, X2 (1, N = 289) =
2.1218, p = 0.145.
Weight change
Mean BMI at time of diagnosis was 26.23 kg/m2 (n =
270, SD 5.43) and at time of survey was 28.02 (n = 285,
SD 5.88). Just under half of women (48.5%) were over-
weight or obese at time of diagnosis, but by the time of
the survey this proportion had risen to 67.3%. This
increase was most marked for women who were obese,
from 17.04% at diagnosis to 31.93% at the time of the
survey. The majority of respondents (63.70%) reported
they had gained weight overall after diagnosis. Of the
women who reported gaining weight overall and for
whom we had complete weight data (n = 175), average
weight gain was 9.07 kg.
Complementary therapy use for any health condition
Figure 1 describes reported CM use for any health con-
dition and associated perceived effectiveness, and Table 2
describes reasons for CM use and information sources.
About three quarters of women (201 or 73.4%) had used
a CM for any health condition in the past 12 months.
The top five CMs used to treat any health condition
were relaxation techniques, yoga, meditation, prayer and
massage. The top three reasons for CM use were to
improve general physical wellbeing (80% of CM users),
reduce stress/improve psychological wellbeing (62% of
CM users), and to treat a condition unrelated to cancer
(37% of CM users). The treatments that women found
most effective were massage, yoga, meditation, acupunc-
ture, and relaxation with more than 50% of women who
had used these therapies strongly agreeing or agreeing
that the treatments had been effective. Most women
sought information on CM from friends and family,
followed by complementary therapists, the internet, GPs,
and specialists. There was no association between CM
use and whether women had gained > 5% of weight
overall or had maintained a stable weight, X2 (1, N =
277) = 0.2017, p = 0.653.
Complementary therapy use for weight loss
Figure 2 describes the number of women who had tried
a CM for weight loss, and perceived effectiveness. A
small number (n = 85, or 31% who completed the entire
survey) of women had tried CM in the last 12 months
for weight loss. The most popular therapies were supple-
ments, yoga, relaxation techniques, massage and medita-
tion. More than 40% of women who had tried yoga,
meditation or pilates agreed or strongly agreed it had
been helpful in relation to weight loss, however the
majority of women felt neutral about the effectiveness of
the therapies they had tried. Table 3 describes the
perceived advantages and disadvantages of using CM for
weight management. The most commonly selected
perceived advantages of using CMs for weight loss were
the ability to improve general wellbeing, relaxation, and
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being non-pharmacological. The major disadvantages
reported were financial cost, finding a reliable practi-
tioner, and lack of research for effectiveness.
When asked which therapies they would try if there
was research to demonstrate effectiveness for weight
loss, almost half of women indicated they would be will-
ing to try acupuncture/acupressure, followed by relax-
ation techniques, yoga, supplements, and meditation
(Fig. 3). Overall, around three quarters of respondents
(237 women) would be willing to try a CM for weight
loss if there was demonstrated scientific evidence for its
effectiveness.
Discussion
In our survey, we found high rates of CM use for any
condition, but lower rates of use for weight management,
with limited perceived effectiveness of the therapies that
had been tried. Women in our survey cited barriers to use
of CM for weight management after BC including lack of
research for effectiveness. However, CM was seen to be
advantageous in improving general wellbeing, providing re-
laxation, and being non-pharmacological. Three quarters of
women would consider a CM if there was evidence for
effectiveness (particularly, acupuncture/acupressure, relax-
ation techniques, yoga, supplements, and meditation).
Almost three quarters of women in our sample had
used a CM in the preceding 12months. This is consist-
ent with evidence from a recent systematic review
reporting prevalence of up to 87% in Australia [3]. CM
users in our sample cited reasons for use such as im-
proving general physical wellbeing, reducing stress/im-
proving psychological wellbeing and treating conditions
unrelated to cancer. Similarly, in another survey, BC sur-
vivors use CMs to “help healing, to promote emotional
health, and to cure cancer” [3]. The most recent survey
conducted in Australia on CM use in BC survivors re-
ported women believed that CMs improved their well-
being, boosted their immune system, reduced side
effects of treatments, reduced symptoms of cancer,
treated the cancer, and prevented recurrence [13]. Can-
cer patients mostly report using CM in an adjunctive
manner, e.g. to improve overall general health and well-
being [14] or to minimize adverse effects from
Table 1 Demographic and clinical characteristics of survey
respondents
Description N (responses) Percentage
State (n = 309)
Australian Capital Territory 14 4.53%
New South Wales 91 29.45%
Northern Territory 0 0.00%
Queensland 48 15.54%
South Australia 28 9.06%
Tasmania 3 0.97%
Victoria 95 30.74%
Western Australia 30 9.71%
Education (n = 307)
High school- year 10 30 9.77%
High school- year 12 35 11.40%
Vocational College 55 17.91%
Bachelor’s degree 90 29.32%
Postgraduate degree 97 31.60%
Ethnicity (n = 308)
European/Anglo Saxon/Caucasian 285 92.53%
Asian 5 1.62%
Oceanic (incl. Australian and
New Zealand first peoples,
Polynesian and Micronesian)
13 4.22%
North/South/Central American 2 0.65%
Mixed ethnicity 2 0.65%
Indian 1 0.33%
Employment (n = 308)
Employee 140 45.46%
Self-employed 33 10.71%
Home duties/caring for children
or family
15 4.87%
In education (going to school,
university, etc.)
4 1.30%
Doing voluntary work 10 3.25%
Unable to work because of illness 6 1.95%
Unable to work for other reasons 1 0.32%
Retired 99 32.14%










Diagnoses (n = 308)
Ductal Carcinoma In Situ (DCIS) 33 10.71%
Table 1 Demographic and clinical characteristics of survey
respondents (Continued)
Description N (responses) Percentage
Localised breast cancer 252 81.82%
Metastatic breast cancer 14 4.55%
Inflammatory breast cancer 2 0.65%
Other including second primary 7 2.27%
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conventional treatment and to prevent further illness
[15]. Collectively, these data suggest that women with
BC seek a range of therapeutic options to optimize all
aspects of their health and wellbeing in a holistic man-
ner, particularly to improve psychological wellbeing.
In our sample, the most commonly used CMs for any
reason were nutraceutical supplements, massage, medi-
tation and yoga which is consistent with what is re-
ported in the literature [3]. Some studies specifically
reported whole medical systems such as naturopathic or
traditional Chinese medicine most commonly used by
BC patients [16, 17]. Of interest, although nutraceutical
supplements were the most commonly used therapy,
about half of women perceived their effectiveness to be
neutral. The therapies with the highest perceived effect-
iveness included massage, acupuncture/acupressure, re-
laxation techniques and yoga.
A smaller proportion (31%) of women had used
CM for weight management. In non-cancer popula-
tions, studies suggest that up to 70% of people with
obesity use CM [18, 19] particularly if they are female
[18]. People with metabolic syndrome are also higher
users of CM [19] compared to people without meta-
bolic syndrome. However, it is unclear if the high use
of CM in people without obesity indicates use specif-
ically for weight management, or if CM are used for
other reasons [18, 19]. We could not find any litera-
ture describing the prevalence of use of CM for
Fig. 1 Complementary therapy use for any condition, and perceived effectiveness
Table 2 Complementary therapy use: Reasons and information
sources
Description Number Percent
Reasons for CM use (n = 201)




Improve a non-cancer related
symptom or condition
75 37.31%
Improve a side effect related to
cancer treatment
51 25.37%
Boost immune system 40 19.90%
Prevent recurrence 39 19.40%
Improve a cancer-related symptom 29 14.43%
Source of CM information (n = 184)
Friend/family 70 38.04%








Social media 8 4.35%
Pharmacist 2 1.09%
CM=Complementary medicine
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weight management in BC survivors. The therapies
were mostly perceived as neutral in terms of effective-
ness, with the exception of yoga and meditation,
which greater than 40% of our sample thought were
effective treatments.
One of the most commonly cited barriers to using CM
in our study was the perceived lack of evidence for ef-
fectiveness. Similarly, in a qualitative study, the most
common reason given for deciding not to use CM
amongst cancer survivors was a lack of meaningful infor-
mation regarding safety and efficacy [15]. However,
around three quarters of women in our sample indicated
that they would try a CM to assist with weight manage-
ment should there be sufficient evidence demonstrating
effectiveness. The most commonly cited CM that would
be chosen in this situation was acupuncture/acupressure,
with around half of women willing to trial these modal-
ities, followed by relaxation techniques, yoga, supple-
ments, and meditation. Indeed, acupuncture shows
promise in the treatment of obesity and overweight in
general populations. A recent meta-analysis reported
that acupuncture, in particular auricular acupuncture
and electro-acupuncture, was more efficacious than
sham acupuncture for reducing BMI (MD − 0.47 kg/m2)
as well as body fat mass (MD − 0.66 kg), waist circumfer-
ence (MD − 2.02 cm) and hip circumference (MD − 2.74
cm) but not for reducing body weight overall [20]. Mech-
anistic studies have suggested multiple responses to
acupuncture including appetite suppression [21, 22],
modulation of leptin and ghrelin [23–25] and improved
Fig. 2 Complementary therapy use for weight loss, and perceived effectiveness
Table 3 Perceived advantages and disadvantages of using
complementary therapies for weight management
Description Number Percent
Perceived advantages of CM use (n = 183)
Improves general wellbeing 139 75.96%
Reduces stress/is relaxing 105 57.38%
Not needing to use drugs/medication 101 55.19%
Can treat other symptoms at the same time 64 34.97%
Holistic approach 57 31.15%
Non-surgical/not needing to have an operation 56 30.60%
Agree with the philosophy behind the therapy 37 20.22%
Already using it 18 9.84%
Perceived disadvantages of CM use (n = 214)
Financial cost 128 59.81%
Lack of research to show it is effective 124 57.94%
Finding a reliable practitioner 99 46.26%
Interactions with medications 58 27.10%
Cannot find reliable information 53 24.77%
Time commitment 37 17.29%
Side effects of treatment 14 6.54%
My GP/specialist does not support its use 13 6.07%
Don’t work/don’t trust 3 1.40%
Unsure 2 0.93%
Motivation to continue 1 0.47%
Too many treatments already 1 0.47%
Goes against my beliefs 1 0.47%
GP=General Practitioner/family physician/primary care physician
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insulin sensitivity [26–31]. Further, acupuncture may
alleviate co-morbid anxiety symptoms in people with
obesity [23, 32, 33]. Given that acupuncture is a relatively
safe treatment [34–36] and may have additional benefits
in women with BC including relief of chemotherapy-
induced peripheral neuropathy [37], aromatase-inhibitor
induced arthralgia [38, 39], menopausal symptoms [40]
and lymphoedema [41], it may represent a useful adjunct-
ive therapy that can assist women in managing a number
of bothersome symptoms and manage weight. To the best
of our knowledge, there are no studies examining the ef-
fectiveness of acupuncture for weight loss in women with
BC, and such research appears warranted.
Women in our sample were also willing to trial medi-
tation, yoga and nutritional supplements for weight
management. In non-BC populations, limited evidence
suggests that mindfulness meditation may help people
improve eating behaviours (such as reducing the amount
of emotional eating), increase physical activity, and re-
duce anxiety and stress [42–47] while two pilot studies
using mindfulness-based techniques for weight manage-
ment in women with BC have reported promising find-
ings for weight loss and eating behaviors [48, 49]. Again
in non-BC populations, yoga may be effective for reduc-
tion of BMI compared with usual care (SMD -0.99) [50],
while a pilot trial in women with BC reported a reduc-
tion in waist circumference of 3.1 cm and improvements
in quality of life [51]. A range of nutraceutical supple-
ments may have modest effects on weight [52–55].
Given the interest in using these complementary modal-
ities to assist weight loss, and the potential for additional
benefits such as for mental health, further clinical re-
search into the effectiveness and efficacy of these low
risk mind-body interventions as an adjunct to lifestyle
interventions is required.
This survey has some strengths and limitations. We
achieved a higher than expected response rate from the
BCNA Review and Survey Group, which is typically 10%
(email communication with BCNA Review and Survey
Group,3 Oct 2017). We were also able to recruit across
Australia, with the percentage of respondents from each
Australian State and Territory in our study being similar
national averages on BC incidence sourced from the
Australian Institute of Health and Welfare cancer data
[56]. However, the majority of women from the BCNA
Review and Survey Group did not respond, and the
demographics of this group are also unclear. Also, the
total numbers of women who used CM for weight man-
agement were small. These factors limit the validity of
our findings.
Conclusion
We found evidence for high prevalence of use of CMs in
a sample of BC survivors to improve wellbeing and re-
lieve symptoms. The use of CM for weight loss is more
limited, most probably due to concerns over lack of
evidence for efficacy and other barriers such as financial
cost. However, three quarters of women in our sample
would be willing to try CMs such as acupuncture/acu-
pressure, meditation, yoga, and nutritional supplements
should there be relevant supporting evidence for efficacy
for weight management. Our findings should be inter-
preted cautiously given the small numbers of women
who were using CM for weight loss, and the low
response rate of our survey. Given the burden of weight
Fig. 3 Complementary therapies that respondents would be willing to try if effective for weight loss
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after BC, further research into these modalities is
warranted.
Appendix
Specific demographic, medical, menopausal and
lymphoedema details requested in the survey
Demographic characteristics
State of residence, highest level of education, ethnicity,
employment status, relationship status, current age and
age at diagnosis were included to describe the character-
istics of women.
Medical details
Women were asked about their diagnosis, treatments re-
ceived including treatments received to the axilla, the
number of lymph nodes removed, whether they had a
reconstruction, use of hormonal treatments, menopausal
state (at diagnosis and current), presence of other med-
ical conditions and symptoms such as hot flushes and
the presence and severity of lymphoedema.
Women were asked to describe the type of breast can-
cer they were diagnosed with as either “ductal cancer in-
situ (DCIS)”, “localised stage breast cancer (where your
breast cancer is contained within your breast and/or
lymph nodes), “metastatic breast cancer (breast cancer
that has spread beyond the breast tissue and lymph
nodes to distant parts of the body, such as the bones,
liver and lungs; also called advanced, secondary or stage
four)“ or “inflammatory breast cancer“. For convenience,
inflammatory breast cancer and metastatic breast cancer
were then combined and referred to as advanced breast
cancer. Women were also asked to indicate the treat-
ments they received such as “Lumpectomy alone”,
“Lumpectomy and radiation”, “mastectomy alone”,
“mastectomy and radiation”, “removal of lymph nodes”,
“chemotherapy”, “hormonal therapy”, “targeted therapy
(Herceptin)”, and “other”. As chemotherapy is invariably
not provided to women with DCIS, we recoded the diag-
nosis as “localised” if a woman indicated that she had re-
ceived chemotherapy.
Menopausal state at the time of diagnosis was assessed
as either “Premenopausal (regular periods with no
menopausal symptoms such as hot flushes)”, “Perimeno-
pausal/in the menopausal transition (no periods for at
least 2 months, plus hot flushes)”, “Postmenopausal (no
periods for at least 12 months)” or “Previous surgical
menopausal (both ovaries or uterus/womb had been re-
moved).” Participants who indicated they were premeno-
pausal or perimenopausal at the time of diagnosis were
asked if they were having periods before breast cancer
treatment and to describe what has happened to their
periods now; “they have stopped”, “they stopped and
then started again”, “they have become more irregular”,
“no change” or “other”.
Lymphoedema severity was defined as either “no prob-
lem (no noticeable swelling)”, “mild (soft swelling that is
not obvious to others and comes and goes)”, “moderate
(swelling with occasional hardness in some areas that is
obvious to others and is always present)”, “severe (pro-
fuse swelling with thickened skin, constant hardness,
and a very large, heavy arm that is extremely obvious to
others and is always present) as described elsewhere [7].”
Lifestyle habits
Women were asked if they had tried the following spe-
cific diets in the previous 12months: Atkins diet (low
carbohydrate), 5:2 diet (eat what you want 5 days a week,
send your body into starvation mode for 2 days),
Paleolithic diet, Dukan diet (High-protein, low-carb),
Vegetarian diet, Vegan diet, Weight Watchers diet, Raw
food diet, Ultra low-fat diet, Zone diet, Cambridge diet
(very low calories), South Beach diet (low-GI), Other.
They were asked if they ate at least the recommended
serves of fruit and vegetables a day (2 fruit, five vege-
table) with answer options of Yes/No. Self-perceived diet
quality was assessed as Excellent/Very Good/Good/Fair/
Poor. Smoking was assessed as current cigarrete use
(Never smoked/Ex smoker/Recently quit ex smoker
(smoked in the last 3 months)/Current smoker) and
current smokers were asked to indicate the number of
cigarettes they smoked each day. Alcohol intake was
assessed as Non drinker/1–7 standard drinks a week/8–
14 standard drinks a week/> 14 standard drinks a week)
and a guide to standard drink sizes was provided. The
validated Weight Self Efficacy Scale (WEL-SF) [3] was
used to evaluate how confident women now felt about
being able to successfully resist the desire to overeat in
eight different situations on an 11-point Likert scale
from 0 (not confident at all) to 10 (very confident). We
further dichotomised the responses into “Not confident”
(0–4) and “Confident” (5–10). Physical activity levels
were calculated according to the number of 20-min ses-
sions of less vigorous exercise or more vigorous exercise
a week, given a weighting and described in terms of
MET (metabolic cost) minutes where MET minutes less
than 80 were coded as no physical activity, 80 to 400 as
low, 400 to 560 as moderate and more than 560 as high.
A value of 4 METs was given to moderate physical activ-
ity and 7.5 to vigorous physical activity [26].
Weight management
Experiences with a range of weight loss interventions
(Exercise, Diet – various: Intermittent fasting, etc.
(please specify), Meal replacements e.g. shakes, Medica-
tion, Weight loss supplements/products, Surgery (please
specify), Online program e.g. 12 week Body Transform-
ation, Social support, Weight loss program e.g. Jenny
Craig, Psychological treatments such as CBT (Cognitive
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Behavioural Therapy) and the perceived effectiveness of
the interventions on was described using a five-point
Likert scale from 1 (not at all effective) to 5 (very effect-
ive). The responses were further dichotomized into 1 to
2 (not effective) and 3 to 5 (effective). Women were also
asked about perceived barriers and facilitators to suc-
cessful weight loss and weight maintenance, and what
they believed should be research priorities in this area.
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